Copyright
©The Author(s) 2023.
World J Clin Cases. Jul 16, 2023; 11(20): 4852-4864
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4852
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4852
Imaging/pathological features | Training group | Validation group | ||
M+ group (n = 40) | M- group (n = 186) | M+ group (n = 17) | M- group (n = 80) | |
Age | 56.15 ± 13.54 | 59.01 ± 10.38 | 65.87 ± 9 .31 | 55.98 ± 10.63 |
Group, n (%) | ||||
BCS | 19 (47.5) | 185 (99.5) | 8 (47.1) | 78 (97.5) |
Non-BCS | 21 (52.5) | 1 (0.5) | 9 (52.9) | 2 (2.5) |
Molecular subtypes, n (%) | ||||
Luminal A | 9 (22.5) | 64 (34.4) | 1 (6.7) | 31 (38.8) |
Luminal B_ Her2(-) | 16 (40.0) | 70 (37.6) | 8 (47.1) | 33 (41.3) |
Luminal B_ Her2(+) | 5 (12.5) | 29 (15.6) | 5 (29.4) | 9 (11.3) |
HER2_ enriched | 6 (15.0) | 6 (3.2) | 2 (11.8) | 4 (5.0) |
TNBC | 4 (10.0) | 17 (9.1) | 0 (0.0) | 3 (3.8) |
Tumor size | 2.5 (1.1-6.0) | 2.08 (0.50-5.40) | 2.27 (1.3-5.0) | 1.95 (0.80-6.70) |
- Citation: Liu P, Zhao Y, Rong DD, Li KF, Wang YJ, Zhao J, Kang H. Diagnostic value of preoperative examination for evaluating margin status in breast cancer. World J Clin Cases 2023; 11(20): 4852-4864
- URL: https://www.wjgnet.com/2307-8960/full/v11/i20/4852.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i20.4852